JAM
RDY icon

Jupiter Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Jupiter Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-93,460
Closed -$1.37M – 631
2021
Q2 		$1.37M Buy
+93,460
New +$1.31M 0.01% 412

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jupiter Asset Management's RDY Position: Q3 2021 in Review

Jupiter Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2021, closing a stake of 93,460 shares — an estimated $1.37M sold.

Jupiter Asset Management first reported a position in RDY in Q2 2021 and held it in 1 quarter. The position peaked at $1.37M in Q2 2021. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

  • Jupiter Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2021 after selling out during the quarter.
  • Jupiter Asset Management sold 93,460 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $1.37M.
  • Jupiter Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2021 and held it in 1 quarter.
  • Jupiter Asset Management's Dr. Reddy's Laboratories position peaked at $1.37M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Jupiter Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.